Viewing Study NCT01861002


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-01-29 @ 5:40 AM
Study NCT ID: NCT01861002
Status: COMPLETED
Last Update Posted: 2021-06-09
First Post: 2013-05-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Organization: